Syndax Pharmaceuticals Inc - Common Stock (SNDX)
CUSIP: 87164F105
Q1 2018 13F Holders as of 31 Mar 2018
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 88,260,257
- Total 13F shares
- 17,173,123
- Share change
- -13,444
- Total reported value
- $244,377,218
- Put/Call ratio
- 165%
- Price per share
- $14.23
- Number of holders
- 72
- Value change
- +$5,182,148
- Number of buys
- 33
- Number of sells
- 33
Quarterly Holders Quick Answers
What is CUSIP 87164F105?
CUSIP 87164F105 identifies SNDX - Syndax Pharmaceuticals Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 87164F105:
Top shareholders of SNDX - Syndax Pharmaceuticals Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.9%
|
3,414,590
|
$29,911,000 | — | 31 Dec 2017 | |
| BVF INC/IL |
13F
|
Company |
3.7%
|
3,233,618
|
$28,326,000 | — | 31 Dec 2017 | |
| MPM ASSET MANAGEMENT LLC |
13F
|
Company |
2.5%
|
2,168,691
|
$18,998,000 | — | 31 Dec 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.3%
|
1,149,730
|
$10,072,000 | — | 31 Dec 2017 | |
| FMR LLC |
13F
|
Company |
0.8%
|
702,844
|
$6,157,000 | — | 31 Dec 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.78%
|
690,882
|
$6,052,000 | — | 31 Dec 2017 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.6%
|
531,028
|
$4,652,000 | — | 31 Dec 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.59%
|
516,500
|
$4,525,000 | — | 31 Dec 2017 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.5%
|
437,000
|
$3,828,000 | — | 31 Dec 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.46%
|
405,360
|
$3,551,000 | — | 31 Dec 2017 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.37%
|
330,910
|
$2,899,000 | — | 31 Dec 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.3%
|
265,601
|
$2,327,000 | — | 31 Dec 2017 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.28%
|
248,472
|
$2,177,000 | — | 31 Dec 2017 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.25%
|
223,758
|
$1,960,000 | — | 31 Dec 2017 | |
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. |
13F
|
Company |
0.23%
|
203,915
|
$1,786,000 | — | 31 Dec 2017 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.23%
|
200,000
|
$1,752,000 | — | 31 Dec 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.17%
|
154,001
|
$1,349,000 | — | 31 Dec 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
153,483
|
$1,344,000 | — | 31 Dec 2017 | |
| Artal Group S.A. |
13F
|
Company |
0.17%
|
150,000
|
$1,314,000 | — | 31 Dec 2017 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.15%
|
135,133
|
$1,172,000 | — | 31 Dec 2017 | |
| TIVERTON ASSET MANAGEMENT LLC |
13F
|
Company |
0.15%
|
132,318
|
$1,159,000 | — | 31 Dec 2017 | |
| UNITED SERVICES AUTOMOBILE ASSOCIATION |
13F
|
Company |
0.14%
|
125,887
|
$1,103,000 | — | 31 Dec 2017 | |
| STATE STREET CORP |
13F
|
Company |
0.13%
|
116,290
|
$1,019,000 | — | 31 Dec 2017 | |
| Boxer Capital, LLC |
13F
|
Company |
0.11%
|
100,000
|
$876,000 | — | 31 Dec 2017 | |
| Crestline Management, LP |
13F
|
Company |
0.09%
|
83,139
|
$728,000 | — | 31 Dec 2017 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.09%
|
81,056
|
$710,000 | — | 31 Dec 2017 | |
| J. Goldman & Co LP |
13F
|
Company |
0.08%
|
71,000
|
$622,000 | — | 31 Dec 2017 | |
| S.c.a. Candriam |
13F
|
Individual |
0.08%
|
70,000
|
$613,000 | — | 31 Dec 2017 | |
| Asymmetry Capital Management, L.P. |
13F
|
Company |
0.07%
|
61,530
|
$539,000 | — | 31 Dec 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.07%
|
58,747
|
$515,000 | — | 31 Dec 2017 | |
| PDT Partners, LLC |
13F
|
Company |
0.06%
|
56,655
|
$496,000 | — | 31 Dec 2017 | |
| Meadow Creek Investment Management LLC |
13F
|
Company |
0.06%
|
54,978
|
$482,000 | — | 31 Dec 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.06%
|
53,384
|
$468,000 | — | 31 Dec 2017 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.06%
|
51,439
|
$451,000 | — | 31 Dec 2017 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
50,500
|
$442,000 | — | 31 Dec 2017 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.06%
|
48,806
|
$428,000 | — | 31 Dec 2017 | |
| Elkfork Partners LLC |
13F
|
Company |
0.05%
|
45,276
|
$397,000 | — | 31 Dec 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.05%
|
45,176
|
$396,000 | — | 31 Dec 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.05%
|
42,273
|
$369,000 | — | 31 Dec 2017 | |
| Trexquant Investment LP |
13F
|
Company |
0.05%
|
40,274
|
$353,000 | — | 31 Dec 2017 | |
| Glen Harbor Capital Management LLC |
13F
|
Company |
0.04%
|
35,574
|
$312,000 | — | 31 Dec 2017 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
32,366
|
$284,000 | — | 31 Dec 2017 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.04%
|
30,930
|
$271,000 | — | 31 Dec 2017 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.03%
|
28,328
|
$248,000 | — | 31 Dec 2017 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.03%
|
27,026
|
$237,000 | — | 31 Dec 2017 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.03%
|
26,068
|
$228,000 | — | 31 Dec 2017 | |
| Neuburgh Advisers LLC |
13F
|
Company |
0.03%
|
25,872
|
$227,000 | — | 31 Dec 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.03%
|
25,700
|
$225,000 | — | 31 Dec 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.03%
|
24,400
|
$214,000 | — | 31 Dec 2017 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.03%
|
23,063
|
$202,000 | — | 31 Dec 2017 |
Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock (SNDX) as of Q1 2018
As of 31 Mar 2018,
Syndax Pharmaceuticals Inc - Common Stock (SNDX) was held by
72 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,173,123 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, BVF INC/IL, MPM ASSET MANAGEMENT LLC, BlackRock Inc., VANGUARD GROUP INC, FMR LLC, ORBIMED ADVISORS LLC, JPMORGAN CHASE & CO, DIMENSIONAL FUND ADVISORS LP, and MILLENNIUM MANAGEMENT LLC.
This page lists
72
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2018 vs Q4 2017 Across Filers
Q4 2017 holders
77
Q1 2018 holders
72
Holder diff
-5
| Investor | Q4 2017 Shares | Q1 2018 Shares | Share Diff | Share Chg % | Q4 2017 Value $ | Q1 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.